ESR1 and breast carcinoma: However, given that the current use of HRT is most strongly associated with risk of ER/PR+HER2− breast cancer and that the prevalence of current HRT use is small,56 we do not expect that adjustment for HRT use would greatly affect our results.20, 57, 58